BioGraphFusion: Graph Fusion in Biomedicine

• BioGraphFusion is a suite of graph fusion methods that integrate heterogeneous biological data using statistical, neural, and Bayesian techniques.
• It employs algorithms like graph attention networks, spectral GCNNs, and Bayesian frameworks to manage missing data, multimodality, and scalability challenges.
• Empirical benchmarks show enhanced disease classification and knowledge graph reasoning, affirming its potential for robust biomedical applications.

BioGraphFusion encompasses a suite of graph fusion paradigms and algorithms designed for integrating, embedding, and reasoning over heterogeneous biological data, multiview graphs, or knowledge graphs. Across its various instantiations, the core aim is to synergistically exploit both the semantic coherence and structural complexity of biomedical graphs, thereby improving capabilities in tasks such as disease classification, biological network inference, and knowledge graph completion or reasoning. The approaches under the BioGraphFusion label traverse statistical Bayesian hierarchies, graph neural attention architectures, and knowledge embedding–graph neural network hybrids, systematically addressing missing data, multi-modality, and high-dimensionality challenges.

1. Problem Domains and Key Challenges

BioGraphFusion is motivated by complex scenarios in biomedicine and neuroscience where networked entities (patients, brain regions, genes, proteins) are observed under multiple modalities or relational types. The following challenges are chiefly addressed:

• Data Incompleteness and Multi-modality: Biomedical datasets are often incomplete, with block-missing features across modalities (MRI, PET, CSF, EEG, fMRI) or partially annotated multi-relational graphs (Vivar et al., 2019, Mirakhorli, 2022).
• Semantic–Structural Gap: Classical knowledge embedding (KE) models capture global semantic regularities but lack dynamic structural adaptivity, while graph neural architectures model local graph neighborhoods but underexploit relational semantics (Lin et al., 19 Jul 2025).
• Scalability: Biological knowledge graphs (KGs) have millions of nodes and edges, demanding computational strategies such as query-guided subgraph construction (Lin et al., 19 Jul 2025).
• Covariate Integration: Subject-level predictors (demographic or phenotypic) must be incorporated into multiview graph inference and uncertainty quantification (Guha et al., 23 Mar 2026).

2. Methodological Frameworks

Several algorithmic frameworks have been developed under the BioGraphFusion label, each suited to different data regimes:

A. Multimodal Graph Neural Fusion

In the context of inductive disease classification with missing modalities, BioGraphFusion employs late fusion of branch-wise Graph Attention Networks (GATs):

• Each modality $m$ is represented by a graph $(A^{(m)}, X^{(m)})$, where $A^{(m)}$ is an $N \times N$ adjacency and $X^{(m)}$ an $N \times F_m$ feature matrix.
• GAT branches compute unnormalized logits $Z^{(m)}$ per modality.
• Missing modality blocks are handled by masking: for patient $i$, if modality $m$ is missing, set $X^{(m)}_i=0$, zero row/column $(A^{(m)}, X^{(m)})$0 in $(A^{(m)}, X^{(m)})$1, and omit $(A^{(m)}, X^{(m)})$2 in fusion.
• The fused logits for $(A^{(m)}, X^{(m)})$3 are $(A^{(m)}, X^{(m)})$4, with $(A^{(m)}, X^{(m)})$5 the set of present modalities.
• Trained end-to-end using node-level cross-entropy, with inductive generalization to out-of-sample patients (Vivar et al., 2019).

B. Joint Graph Representation for Multimodal Brain Data

In neuroimaging, BioGraphFusion constructs separate spectral graph convolutional networks (GCNNs) for EEG and fMRI, extracting saliency via CAM, then applying multiview GATs and cross-attention mechanisms for alignment and fusion:

• Node features are BOLD or multichannel EEG time series.
• Modality-specific similarity graphs are built using Gaussian kernels or k-nearest-neighbors; cross-modal edges via cosine similarity over CAM saliency vectors.
• Final node embeddings are formed via a fusion layer with learned importance weights.
• total loss comprises reconstructed view-geometry plus standard regularization (Mirakhorli, 2022).

C. Bayesian Multiview Graph Fusion with Covariates

A Bayesian framework allows exact inferential and predictive integration of multiple graph views and covariates:

• Each subject $(A^{(m)}, X^{(m)})$6 provides $(A^{(m)}, X^{(m)})$7 undirected network views $(A^{(m)}, X^{(m)})$8 on common node set, plus predictor vectors $(A^{(m)}, X^{(m)})$9.
• Edge values (binary or continuous) for each view are modeled with a GLM: $A^{(m)}$0.
• A hierarchical low-rank prior factorizes $A^{(m)}$1 as $A^{(m)}$2, with joint spike-and-slab variable selection across views.
• Posterior sampling is realized via a modular Gibbs scheme, allowing credible-interval UQ for edges/functions and predictive inference for new subjects. Theoretical consistency is established under mild conditions (Guha et al., 23 Mar 2026).

D. Semantic-Structural Synergistic KG Reasoning

BioGraphFusion for KG completion/reasoning introduces a deeply intertwined architecture:

• Global semantic representations are learned via CP tensor decomposition of KG adjacency tensor $A^{(m)}$3.
• Structural learning operates over a query-guided subgraph, refining relation embeddings with an LSTM-based Contextual Relation Refinement (CRR) across $A^{(m)}$4 propagation layers.
• Message passing utilizes query-conditioned attention mechanisms.
• Scoring fuses graph and semantic tracks: $A^{(m)}$5.
• Training uses multi-class log loss and N3 regularization, with performance validated against KE, GNN, and ensemble baselines (Lin et al., 19 Jul 2025).

3. Experimental Benchmarks and Results

BioGraphFusion variants have been empirically validated across tasks and datasets:

Study [year]	Task / Data	Best Reported Metric(s)	Comparison Models
(Vivar et al., 2019)	Disease classification / TADPOLE (ADNI)	Accuracy: 72.6% (GAT-Fusion), ROC 0.57	RF, linear SVC, GAT-Imp
(Vivar et al., 2019)	Toy MNIST w/ 50% block-missing	Accuracy: ≈90.3% (GAT-Fusion)	RF, GAT-Imp
(Guha et al., 23 Mar 2026)	fMRI connectivity + covariates	MSPE: 9% (JL) improvement over IL; node selection	IL, tensor regression (TL)
(Lin et al., 19 Jul 2025)	KG completion (DisGeNET, STITCH, UMLS)	MRR: 0.429 (disease-gene), 0.702 (protein-chemical), 0.974 (UMLS)	RotatE, RED-GNN, StAR, etc.

Paired t-tests confirm statistically significant improvements of BioGraphFusion over all tested baselines ($A^{(m)}$6) for biomedical KG completion/reasoning (Lin et al., 19 Jul 2025). Ablation studies indicate that omitting graph propagation (–GSP), LSTM-based CRR (–CRR), or the global CP semantic module (–$A^{(m)}$7) all result in notable MRR drops.

A case study on Cutaneous Malignant Melanoma 1 highlighted the framework's capability to suggest biologically validated gene-disease associations and reconstruct high-confidence PPI subnetworks; pathway enrichment and attention-based reasoning paths were aligned with current molecular knowledge.

4. Handling Missing Data and Uncertainty

BioGraphFusion methods are explicitly designed to address block-missing or incomplete multiview data:

• In GAT-Fusion, missing modalities per node are handled by masking at the graph and feature level; neither imputation nor gating is required, and fusion is performed only over observed branches (Vivar et al., 2019).
• The Bayesian graph fusion framework incorporates uncertainty quantification directly via the posterior, with credible intervals, posterior predictive densities, and region/node-level selection probabilities all available (Guha et al., 23 Mar 2026).
• Emphasis on query-guided subgraph construction in KG scenarios additionally controls for irrelevant or noisy node expansion, enhancing interpretability and robustness (Lin et al., 19 Jul 2025).

5. Extensions, Limitations, and Future Directions

Current limitations and promising future directions include:

• Cross-modality interaction: Present late-fusion paradigms may under-utilize higher-order inter-modality connections; extensions to early/mid-fusion via learned adjacency or hierarchical attention are proposed (Vivar et al., 2019).
• Scalability and Efficient Inference: Query-guided subgraph sampling provides a tractable approach for massive KGs, but dynamic scalability to temporal or context-specific graphs remains an open avenue (Lin et al., 19 Jul 2025).
• Integration of Textual/Omics Evidence: Future versions aim to incorporate textual sources (papers, patents) via pre-trained LLMs, as well as other omics or clinical time-series by modular branch addition (Lin et al., 19 Jul 2025, Vivar et al., 2019).
• Denoising and Robust Saliency: Replacing or augmenting CAM-derived node selection with artifact-robust or denoising criteria has been suggested (Mirakhorli, 2022).
• Theoretical Guarantees: The hierarchical Bayesian construction has provable consistency under specified asymptotics; extensions to richer dependency structures and high-dimensional regime theory are plausible (Guha et al., 23 Mar 2026).

6. Impact, Applications, and Availability

BioGraphFusion methodologies have demonstrated:

• Improved disease classification under incomplete, multimodal clinical settings (Vivar et al., 2019).
• High-spatio-temporal brain network recoveries unachievable by single-modality approaches (Mirakhorli, 2022).
• Statistically consistent, interpretable multiview graph inference that aligns with biological domain knowledge (Guha et al., 23 Mar 2026).
• State-of-the-art KG completion and multi-hop reasoning on biomedical resource graphs, with direct evidence for biological pathway discovery and gene association inference (Lin et al., 19 Jul 2025).

Codebases and processed datasets for key variants are available, notably for KG completion tasks at https://github.com/Y-TARL/BioGraphFusion (Lin et al., 19 Jul 2025).

---

BioGraphFusion, as instantiated across several research domains, reflects a methodological shift towards tightly integrated semantic-structural graph modeling, extending from multimodal disease risk prediction and neuroscience inference, to cutting-edge reasoning over biological knowledge graphs.